APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, the CML+apoA-I group showed a 37%-lower AO-stained area (p < 0.001) than the CML+PBS group, while the CML+CIGB-258 group exhibited a 53%-lower AO-stained area (p < 0.001).